Medicare Enrolled

Dr. Martin Taylor, D.O.

Neurology · New Albany, OH
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
5040 FOREST DR, New Albany, OH 43054
6148906555
In practice since 2005 (20 years)
NPI: 1043294481 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Taylor from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Taylor? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Taylor

Dr. Martin Taylor is a neurology specialist in New Albany, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Taylor performed 39,902 Medicare services across 770 unique beneficiaries.

Between the years covered by Open Payments, Dr. Taylor received a total of $810,388 from 34 pharmaceutical and/or device companies across 1005 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Taylor is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 0% volume in OH $810,388 industry payments

Medicare Practice Summary

Medicare Utilization ↗
39,902
Medicare services
Top 0% in OH for neurology
770
Unique beneficiaries
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,995 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
38,575 $5 $12
Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle 157 $56 $120
Chemical nerve block injection, 1-4 muscles
An injection of a chemical agent to paralyze specific muscles in an arm or leg. This procedure targets one to four muscles in the first extremity treated.
144 $61 $343
Chemical nerve block for neck muscles
Injection of a chemical agent to paralyze specific muscles on the side of the neck, excluding the voice box.
130 $140 $592
Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity 122 $70 $227
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
122 $70 $190
Chemical nerve block injection, trunk muscles
An injection of a chemical agent to temporarily paralyze specific muscles in the trunk area. The procedure involves treating between one and five muscles.
115 $59 $369
Chemical nerve block for facial paralysis
Injection of a chemical agent to paralyze specific nerves or muscles on the side of the face.
106 $92 $741
Injection of anesthetic agent and/or steroid into other nerve or branch 76 $30 $304
Methylprednisolone acetate injection, 80 mg
An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication.
62 $9 $20
Nerve conduction studies, 5-6 tests
A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction.
61 $92 $290
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
47 $114 $276
Injection of anesthetic or steroid into upper neck and back of head nerve
An injection of an anesthetic agent and/or steroid into a nerve located in the upper neck and back of the head.
40 $65 $324
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
31 $88 $177
Nerve conduction study, 9-10 studies
A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function.
30 $150 $392
Ultrasound guidance for needle placement
Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure.
28 $42 $372
Trigger point injection, 3 or more muscles
Injection of medication into three or more specific muscle trigger points to relieve pain.
24 $30 $149
New patient office visit, complex (60-74 min) 16 $129 $344
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
16 $64 $150
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$810,388
Total received (2018-2024)
Avg $115,770/year across 7 years
Top 1% in OH for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
1,005
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$783,666 (96.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$22,471 (2.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,251 (0.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$117,614
2023
$73,241
2022
$103,973
2021
$165,148
2020
$94,160
2019
$133,694
2018
$122,557

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$117,121
Lundbeck LLC
$246
ACADIA Pharmaceuticals Inc
$121
REVANCE THERAPEUTICS, INC.
$45
Tonix Medicines, Inc.
$34
PFIZER INC.
$29
Acorda Therapeutics, Inc
$18
Top 3 companies account for 99.9% of 2024 payments
All-time payments by company (2018-2024) ›
Allergan, Inc.
$208,268
ABBVIE INC.
$177,670
Allergan Inc.
$109,679
AbbVie Inc.
$106,387
Amgen Inc.
$95,286
Biohaven Pharmaceuticals, Inc.
$38,897
Teva Pharmaceuticals USA, Inc.
$22,566
Ipsen Biopharmaceuticals, Inc
$13,475
Biohaven Pharmaceutical Holding Company Ltd.
$13,194
US WorldMeds, LLC
$12,319
Assertio Therapeutics, Inc.
$6,272
Lundbeck LLC
$2,506
ACADIA Pharmaceuticals Inc
$790
Ipsen Pharma SAS
$674
Lilly USA, LLC
$415
IMPEL PHARMACEUTICALS INC.
$341
Biogen, Inc.
$271
Kyowa Kirin, Inc.
$186
PFIZER INC.
$169
Abbott Laboratories
$130
Stimwave Technologies Incorporated
$130
Acorda Therapeutics, Inc
$129
Adamas Pharmaceuticals, Inc.
$119
SK Life Science, Inc.
$101
Neurocrine Biosciences, Inc.
$85
AbbVie, Inc.
$80
UCB, Inc.
$74
UPSHER-SMITH LABORATORIES LLC
$46
REVANCE THERAPEUTICS, INC.
$45
Tonix Medicines, Inc.
$34
Saol Therapeutics Inc.
$15
Horizon Therapeutics plc
$13
Novartis Pharmaceuticals Corporation
$13
Supernus Pharmaceuticals, Inc.
$11
Top 3 companies account for 61.2% of all-time payments
Associated products mentioned in payments ›
AJOVY · APOKYN · AUSTEDO · Aimovig · BOTOX · BOTOX - NEUROLOGY · BOTOX THERAPEUTIC · Briviact · COMIRNATY · Cenobamate · DAXXIFY · DUOPA · DYSPORT · Duopa · Dysport · EMGALITY · GILENYA · GOCOVRI · Gralise · INBRIJA · INGREZZA · Lioresal Intrathecal (baclofen injection) · MYOBLOC · NOURIANZ · NUPLAZID · NURTEC ODT · PAXLOVID · PROCLAIM · QULIPTA · StimQ Receiver Stimulator Kit Channel A US w/Receiver · TECFIDERA · TOSYMRA · TROKENDI XR · Trudhesa · Tysabri · UBRELVY · UPLIZNA · VYALEV · VYEPTI · Vimpat · Xadago · ZEMBRACE SYMTOUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (97%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for neurology in OH.

Looking for a neurology specialist in New Albany?
Compare neurologists in the New Albany area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
170
Per 100K population
12.9
County median income
$73,795
Nearest hospital
MOUNT CARMEL NEW ALBANY SURGICAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Taylor is a mixed practice specialist, with above-average Medicare volume (top 0% in OH), with speaking/promotional industry engagement in the top 1% of OH peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Taylor experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Taylor performed 38,575 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Taylor receive payments from pharmaceutical companies?
Yes. Dr. Taylor received a total of $810,388 from 34 companies across 1,005 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Taylor's costs compare to other neurologists in New Albany?
Dr. Taylor's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Taylor) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →